Penumbra, Inc. (PEN)
Company Info
Highlights
$11.19B
$1.07
270.07
-62.27
$1.24B
$787.25M
$72.64M
$148.00 - $310.00
$318.59
5.57%
2.80
Share Price Chart
Loading data...
Compare to other instruments
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Performance
Performance Chart
Loading data...
Returns By Period
Penumbra, Inc. (PEN) returned 15.93% year-to-date (YTD) and 34.50% over the past 12 months.
PEN
15.93%
1.12%
17.91%
34.50%
10.01%
N/A
^GSPC (Benchmark)
0.60%
9.64%
-0.54%
11.47%
15.67%
10.79%
Monthly Returns
The table below presents the monthly returns of PEN, with color gradation from worst to best to easily spot seasonal factors. Returns are adjusted for dividends.
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Total | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025 | 12.42% | 6.92% | -6.32% | 9.51% | -5.98% | 15.93% | |||||||
| 2024 | 0.26% | -6.85% | -5.00% | -11.97% | -3.56% | -5.01% | -7.16% | 21.08% | -3.96% | 17.79% | 6.66% | -2.72% | -5.59% |
| 2023 | 12.56% | 3.83% | 7.19% | 1.95% | 8.17% | 11.95% | -11.83% | -12.81% | -8.54% | -20.98% | 16.19% | 13.26% | 13.07% |
| 2022 | -21.34% | -1.89% | 0.18% | -22.32% | -14.86% | -15.25% | 11.93% | 17.79% | 15.49% | -9.56% | 22.18% | 6.18% | -22.57% |
| 2021 | 49.19% | 8.94% | -4.87% | 13.09% | -18.59% | 10.02% | -2.86% | 3.28% | -3.07% | 3.77% | -11.17% | 16.96% | 64.18% |
| 2020 | 6.81% | -5.47% | -2.73% | 9.91% | -2.76% | 3.71% | 24.10% | -5.75% | -7.06% | 34.29% | -14.99% | -21.14% | 6.53% |
| 2019 | 19.08% | -8.14% | 9.98% | -8.51% | 6.10% | 12.12% | 4.75% | -13.16% | -7.60% | 15.97% | 13.43% | -7.15% | 34.43% |
| 2018 | 5.84% | 8.63% | 6.89% | 7.52% | 29.39% | -14.14% | 2.97% | -2.39% | 7.81% | -9.15% | 2.37% | -12.23% | 29.86% |
| 2017 | 12.15% | 7.34% | 8.66% | 2.40% | -3.04% | 5.91% | -6.95% | 5.33% | 5.00% | 11.35% | 4.72% | -10.64% | 47.49% |
| 2016 | -20.46% | 8.93% | -1.33% | 18.48% | -3.14% | 12.71% | 14.81% | 3.29% | 7.70% | -13.21% | -6.14% | 3.07% | 18.57% |
| 2015 | -2.91% | -7.66% | 35.89% | 6.94% | 30.29% |
Risk-Adjusted Performance
Risk-Adjusted Performance Rank
With an overall rank of 79, PEN is among the top 21% of stocks on our website when it comes to balancing risk and reward. Below is a breakdown of how it compares using common performance measures.
Risk-Adjusted Performance Indicators
The charts below present risk-adjusted performance metrics for Penumbra, Inc. (PEN) and compare them to a chosen benchmark (^GSPC). These indicators evaluate an investment's returns against its associated risks.
Loading data...
Dividends
Dividend History
Drawdowns
Drawdowns Chart
The Drawdowns chart displays portfolio losses from any high point along the way. Drawdowns are calculated considering price movements and all distributions paid, if any.
Loading data...
Worst Drawdowns
The table below displays the maximum drawdowns of the Penumbra, Inc.. A maximum drawdown is a measure of risk, indicating the largest reduction in portfolio value due to a series of losing trades.
The maximum drawdown for the Penumbra, Inc. was 62.64%, occurring on Jun 16, 2022. Recovery took 224 trading sessions.
The current Penumbra, Inc. drawdown is 19.98%.
Depth | Start | To Bottom | Bottom | To Recover | End | Total |
|---|---|---|---|---|---|---|
| -62.64% | Apr 29, 2021 | 287 | Jun 16, 2022 | 224 | May 9, 2023 | 511 |
| -52.44% | Jul 3, 2023 | 277 | Aug 7, 2024 | — | — | — |
| -35.86% | Nov 13, 2020 | 23 | Dec 16, 2020 | 36 | Feb 9, 2021 | 59 |
| -35.83% | Feb 20, 2020 | 23 | Mar 23, 2020 | 74 | Jul 8, 2020 | 97 |
| -31.65% | Jun 7, 2018 | 139 | Dec 24, 2018 | 118 | Jun 14, 2019 | 257 |
Volatility
Volatility Chart
The chart below shows the rolling one-month volatility.
Loading data...
Financials
Financial Performance
The chart below illustrates the trends in the financial health of Penumbra, Inc. over time, highlighting three key metrics: Total Revenue, Earnings Before Interest and Taxes (EBIT), and Net Income.
Earnings Per Share
The chart presents the Earnings Per Share (EPS) performance of Penumbra, Inc., comparing actual results with analytics estimates. The company has exceeded analyst expectations for EPS in the past quarter, achieving a 10.0% positive surprise.
Valuation
The Valuation section provides an overview of how Penumbra, Inc. is priced in the market compared to other companies in the Medical Devices industry. It includes key financial ratios that help investors assess whether the stock is undervalued or overvalued.
PE Ratio
The chart displays the Price-to-Earnings (P/E) ratio for PEN, comparing it with other companies in the Medical Devices industry. Currently, PEN has a P/E ratio of 270.1. This P/E ratio is significantly higher than those of industry peers. This could indicate that the stock is overvalued or that investors expect strong future growth.
PEG Ratio
The chart shows the Price/Earnings to Growth (PEG) ratio for PEN compared to other companies in the Medical Devices industry. PEN currently has a PEG ratio of -62.3. This PEG ratio is negative, which typically signals that the company's earnings are expected to decline. A negative PEG is not considered meaningful for valuation purposes.
PS Ratio
This chart shows the Price-to-Sales (P/S) ratio for PEN relative to other companies in the Medical Devices industry. Currently, PEN has a P/S ratio of 9.0. This P/S ratio is high relative to other companies in the industry. It could mean the stock is overvalued, or that investors expect strong future growth and profitability.
PB Ratio
The chart illustrates the Price-to-Book (P/B) ratio for PEN in comparison with other companies in the Medical Devices industry. Currently, PEN has a P/B value of 9.2. This P/B ratio is higher than most companies in the industry. It may suggest the stock is overvalued or that investors expect the company to generate high returns on its assets.
Income Statement
| TTM | |
|---|---|
Revenue | — |
Total Revenue | — |
Cost Of Revenue | — |
Gross Profit | — |
Operating Expenses | — |
Selling, General & Admin Expenses | — |
R&D Expenses | — |
Depreciation And Amortization | — |
Total Operating Expenses | — |
Income | — |
Income Before Tax | — |
Operating Income | — |
EBITDA | — |
EBIT | — |
Earnings From Continuing Operations | — |
Net Income | — |
Income Tax Expense | — |
Other Non-Operating Income (Expenses) | — |
Extraordinary Items | — |
Discontinued Operations | — |
Effect Of Accounting Charges | — |
Non Recurring | — |
Minority Interest | — |
Other Items | — |
Interest Income | — |
Interest Expense | — |
Net Interest Income | — |